Personalized blood clot prevention for pregnant women put to the test
NCT ID NCT03659708
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a special scoring tool (the Lyon-VTE score) can better prevent dangerous blood clots in pregnant women at high risk compared to standard care. About 600 pregnant women with a personal history of blood clots or a clotting disorder will be randomly assigned to either score-guided prevention or usual recommendations. The goal is to see if personalized care is safer, more effective, and more cost-efficient.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Lyon-VTE score (risk assessment tool)
What this could lead to
If successful, this could provide a validated, personalized approach to prevent dangerous blood clots during pregnancy, reducing unnecessary treatment and costs.
What could go wrong
This is a relatively early-stage trial (phase not specified) and the score has only been tested in retrospective and small prospective studies. It may not prove more effective or cost-saving than current care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hôpital Cardiologique L. Pradel
RECRUITINGBron, 69677, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact